Growth Metrics

Cumberland Pharmaceuticals (CPIX) Net Income towards Common Stockholders (2016 - 2026)

Cumberland Pharmaceuticals' Net Income towards Common Stockholders history spans 15 years, with the latest figure at -$1.1 million for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders rose 32.41% to -$1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.5 million, a 59.03% increase, with the full-year FY2025 number at -$2.5 million, up 59.03% from a year prior.
  • Net Income towards Common Stockholders hit -$1.1 million in Q4 2025 for Cumberland Pharmaceuticals, up from -$1.9 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for CPIX hit a ceiling of $1.2 million in Q1 2025 and a floor of -$6.3 million in Q4 2023.
  • Historically, Net Income towards Common Stockholders has averaged -$794191.7 across 4 years, with a median of -$899213.0 in 2023.
  • Biggest five-year swings in Net Income towards Common Stockholders: crashed 1204.25% in 2024 and later surged 165.61% in 2025.
  • Tracing CPIX's Net Income towards Common Stockholders over 4 years: stood at $503318.0 in 2021, then plummeted by 1352.09% to -$6.3 million in 2023, then surged by 74.66% to -$1.6 million in 2024, then skyrocketed by 32.41% to -$1.1 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for CPIX at -$1.1 million in Q4 2025, -$1.9 million in Q3 2025, and -$735207.0 in Q2 2025.